Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
New England Journal of Medicine2014Vol. 371(26), pp. 2488–2498
Citations Over TimeTop 1% of 2014 papers
Siddhartha Jaiswal, Pierre Fontanillas, Jason Flannick, Alisa K. Manning, Peter Grauman, Brenton G. Mar, R. Coleman Lindsley, Craig H. Mermel, Noël P. Burtt, Alejandro Chavez, John M. Higgins, Vladislav Moltchanov, Frank C. Kuo, Michael Kluk, Brian E. Henderson, Leena Kinnunen, Heikki A. Koistinen, Claes Ladenvall, Gad Getz, Adolfo Correa, Benjamin F. Banahan, Stacey Gabriel, Sekar Kathiresan, Heather M. Stringham, Mark I. McCarthy, Michael Boehnke, Jaakko Tuomilehto, Christopher Haiman, Leif Groop, Gil Atzmon, James G. Wilson, Donna Neuberg, David Altshuler, Benjamin L. Ebert
Abstract
Age-related clonal hematopoiesis is a common condition that is associated with increases in the risk of hematologic cancer and in all-cause mortality, with the latter possibly due to an increased risk of cardiovascular disease. (Funded by the National Institutes of Health and others.).
Related Papers
- → Current Role of Genetics in Hematologic Malignancies(2015)26 cited
- → Metabolic syndrome in hematologic malignancies survivors: a meta-analysis(2014)20 cited
- Angiogenesis in hematologic malignancies.(2002)
- → Guest editorial: Epigenetics of hematopoiesis and hematological malignancies(2012)
- → Hematologic and Oncologic Disorders: Selected Hematologic Disorders(2018)